A. Henry

发表

Evaluation of Oncological Outcomes and Data Quality in Studies Assessing Nerve-sparing Versus Non-Nerve-sparing Radical Prostatectomy in Nonmetastatic Prostate Cancer: A Systematic Review.

H. G. van der Poel, R. V. D. van den Bergh, T. Wiegel, 2021, European urology focus.

Gene and pathway level analyses of germline DNA-repair gene variants and prostate cancer susceptibility using the iCOGS-genotyping array

J. R. Wilson, David M. Holden, P. W. Foster, 2016, British Journal of Cancer.

Radiotherapy to the prostate for men with metastatic prostate cancer in the UK and Switzerland: Long-term results from the STAMPEDE randomised controlled trial

M. Sydes, D. Dearnaley, C. Parker, 2022, PLoS medicine.

This is a repository copy of STAMPEDE: Is Radiation Therapy to the Primary a New Standard of Care in Men with Metastatic Prostate Cancer?

D. Spratt, M. Pinkawa, T. Mitin, 2020 .

Reirradiation Options for Previously Irradiated Prostate cancer (RO-PIP): Feasibility study investigating toxicity outcomes following reirradiation with stereotactic body radiotherapy (SBRT) versus high-dose-rate brachytherapy (HDR-BT)

D. Buckley, A. Scarsbrook, P. Hoskin, 2022, BMJ Open.

External beam radiotherapy (EBRT) and high-dose rate (HDR) brachytherapy for intermediate and high-risk prostate cancer: the impact of EBRT volume.

P. Hoskin, A. Choudhury, R. Alonzi, 2020, International journal of radiation oncology, biology, physics.

Cancer-related symptoms, mental well-being, and psychological distress in men diagnosed with prostate cancer treated with androgen deprivation therapy

A. Gavin, M. Mason, P. Selby, 2019, Quality of Life Research.

ESTRO-ACROP recommendations for evidence-based use of androgen deprivation therapy in combination with external-beam radiotherapy in prostate cancer.

T. Wiegel, M. Mason, C. Belka, 2023, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Prediction of prostate tumour hypoxia using pre-treatment MRI-derived radiomics: preliminary findings

A. Scarsbrook, P. Hoskin, A. McWilliam, 2023, La radiologia medica.

Short-Term Toxicity of HDR Brachytherapy In Prostate Cancer Patients With Inflammatory Bowel Disease

P. Hoskin, A. Robinson, A. Nikapota, 2019 .

The value of MR textural analysis in prostate cancer.

A. Scarsbrook, A. Henry, N. Patel, 2019, Clinical radiology.

Real-world Outcomes and Factors Predicting Survival and Completion of Radium 223 in Metastatic Castrate-resistant Prostate Cancer.

D. Bottomley, A. Henry, S. Dixit, 2018, Clinical oncology (Royal College of Radiologists (Great Britain)).